Physician profile
Brian Suk Lee
NPI 1073545216
$10,982.02
in general payments reported to CMS, 2019-2025
10 companies · $177 in 2025
The $177 reported for 2025 was more than what 80% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $276 · 2021: $452 · 2022: $6,299 · 2023: $3,301 · 2024: $215 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,800 · Food and Beverage: $874 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,800.00 |
| Food and Beverage | $873.59 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $9,301.24 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $863.68 | 2019-2024 | Xarelto |
| Abiomed | $237.16 | 2023-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $218.41 | 2019-2023 | |
| Pfizer INC. | $172.15 | 2019-2025 | |
| Gilead Sciences, INC. | $70.62 | 2022 | |
| Csl Behring | $68.34 | 2021-2024 | Kcentra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.83 | 2025 | Xifaxan |
| Glaxosmithkline, LLC. | $13.43 | 2019 | |
| Chiesi USA, INC. | $12.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.